NCT05931549

Brief Summary

EXCENTRICC is a platform for scientific collaboration between different disciplines, all working on a common theme: adrenocortical hormones. In this EXCENTRICC sub-study, associations are studied between cortisol levels and depression, anxiety, disease severity and hippocampal and insula volume in the brain in anorexia nervosa.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
7mo left

Started Sep 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress83%
Sep 2023Dec 2026

First Submitted

Initial submission to the registry

February 20, 2023

Completed
5 months until next milestone

First Posted

Study publicly available on registry

July 5, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

September 1, 2023

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Expected
Last Updated

February 21, 2024

Status Verified

February 1, 2024

Enrollment Period

2.3 years

First QC Date

February 20, 2023

Last Update Submit

February 19, 2024

Conditions

Keywords

anorexia nervosaCortisolInsulaHippocampus

Outcome Measures

Primary Outcomes (4)

  • Hippocampus total volumen (cm3)

    MRI

    Cross sectional (AN patients during a treatment course)

  • Insula total volumen (cm3)

    MRI

    (AN patients during a treatment course)

  • Plasma cortisol level (mmol/l)

    AN patients during a treatment course at any time in relation to the duration of the illness and course of treatment.

  • Cortisol diurnal excretion (nmol/d)

    AN patients during a treatment course at any time in relation to the duration of the illness and course of treatment.

Secondary Outcomes (4)

  • Symptom severity

    AN patients during a treatment course at any time in relation to the duration of the illness and course of treatment.

  • Depression

    AN patients during a treatment course at any time in relation to the duration of the illness and course of treatment.

  • Anxiety

    AN patients during a treatment course at any time in relation to the duration of the illness and course of treatment.

  • Quality of life

    AN patients during a treatment course at any time in relation to the duration of the illness and course of treatment.

Study Arms (2)

Patients in treatment for severe anorexia nervosa

Treatment as usual.

Age matched healthy controls

No treatment.

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsThe disease anorexia nervosa is predominantly observed in women (approximately 95%).
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Women with anorexia nervosa, treatment seeking at Center for Eating Disorders at Odense University Hospital or via advertising on social media.

You may qualify if:

  • Women who fulfill the criteria for AN according to the Diagnostic and Statistical Manual of Mental Disorders (DSM), version 5 (APA, 2013).
  • BMI \< 16.

You may not qualify if:

  • Current treatment with glucocorticoids.
  • Current use of oral contraceptives.
  • Unstable acute somatic comorbidity, e.g., infection.
  • Any kind of metal prostheses or -implants.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Odense University Hospital

Odense, 5000, Denmark

RECRUITING

Biospecimen

Retention: SAMPLES WITHOUT DNA

Blood, saliva, urine, hair

MeSH Terms

Conditions

Anorexia Nervosa

Condition Hierarchy (Ancestors)

Feeding and Eating DisordersMental Disorders

Study Officials

  • René K Støving, PhD

    Odense University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

René K Støving, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 20, 2023

First Posted

July 5, 2023

Study Start

September 1, 2023

Primary Completion

December 1, 2025

Study Completion (Estimated)

December 1, 2026

Last Updated

February 21, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Locations